Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
NVDA$184.33-15.96(-7.97%)Historically Bullish Signal Emerges for Nvidia Stock2:37:37 PM ETCOP$137.30+0.42(+0.31%)UPDATE 4-ConocoPhillips boosts dividend after beating estimates on higher oil prices2:33:40 PM ETMCD$276.81-3.42(-1.22%)McDonald's plans new value menu offerings next year to boost sluggish sales2:33:15 PM ETTSLA$344.39-40.79(-10.59%)The ‘Musk selloff' deepens as Tesla and SpaceX combine for $450 billion two-day wipeout2:29:00 PM ETPLTR$156.34-15.40(-8.97%)Prediction: These Will Be Nvidia's and Palantir's Stock Prices by 2027 (Hint: Only 1 Is a Buy)2:26:00 PM ETCOP$137.30+0.42(+0.31%)BRIEF-Conocophillips Says Q4 Forecast Incorporates Uncertainty Around Qatar Production Levels2:21:59 PM ETTSLA$344.39-40.79(-10.59%)SpaceX, Tesla extend losses as midterm results cloud data center, merger outlook2:18:16 PM ETTSLA$344.39-40.79(-10.59%)If You Invested $1,000 in Tesla at Its 2010 IPO, Here's What You'd Have Today2:17:42 PM ETNVDA$184.33-15.96(-7.97%)Nvidia stock plunges 8% as AI spending fears and financing risks mount2:13:33 PM ETMETA$606.73-22.94(-3.64%)Meta's warns that election backlash against data centers could make AI expansion harder2:12:39 PM ETGS$872.61-55.67(-6.00%)UPDATE 1-Goldman Sachs promotes 109 bankers to partner ranks but omits demographic data2:11:01 PM ETGOOG$283.80-3.66(-1.27%)What Should Alphabet Inc. Investors Know After 7.13% Stock Drop? The Law Offices of Frank R.2:10:00 PM ETTMUS$159.50+0.39(+0.25%)Sorry to Wake You, But T-Mobile and Bryan Cranston Have a Change in Plans2:06:02 PM ETAMD$419.85-68.84(-14.09%)Some of the Year's Hottest AI ETFs Are in Big Trouble Today2:03:23 PM ETMGHL$2.200.00(0.00%)Cisco Falls 7% on Morgan Stanley Downgrade; Ciena Plunges 15%, Arista Networks Tumbles 10%2:03:05 PM ETBRK-A$859,951.40-8,663.60(-1.00%)Pilot Celebrates 2026 Road Warrior Champion with Customized Kenworth W990 Truck and $50,000 Cash Prize2:02:00 PM ETPLTR$156.34-15.40(-8.97%)Why Is Palantir Stock Falling, and is it a Buying Opportunity?2:00:02 PM ETNVDA$184.33-15.96(-7.97%)As Nvidia's stock heads for a bear market, bargain hunters see a golden buying opportunity1:59:00 PM ETPLTR$156.34-15.40(-8.97%)Palantir Just Had Its Best Growth Quarter Ever. Why Are Investors Selling?1:57:22 PM ETACCS$3.49-0.09(-2.51%)The Mortgage Office Launches AI Portfolio Tools to Help Private Lenders Spot Risk Earlier and Get More from Their Data1:55:00 PM ETMETA$606.73-22.94(-3.64%)BRIEF-Meta Rolls Out Voice And Expressive Avatars In Muse App1:54:43 PM ETAMZN$260.90-5.29(-1.99%)UPDATE 1-Anthropic's models improving nearly twice as fast with help from AI, study finds1:53:21 PM ETAAPL$344.68-4.88(-1.40%)Apple Taps Bond Market for $7B as Tech Sells Off1:49:34 PM ETTSLA$344.39-40.79(-10.59%)Tesla, SpaceX Slide as Investors Price in Political Risk1:48:27 PM ET

CERT · NASDAQ

Certara, Inc.

$11.93 +0.83 (+7.48%)

Company overview

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company uses biosimulation software, technology, and services to transform drug discovery and development, helping to bring medicines to patients. It also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. These technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$1.8B
Employees
1,487
Headquarters
Princeton, NJ
Website
certara.com
CEO
Jon Resnick
Listed
December 11, 2020
P/E
-124.79
Dividend yield
0.00%

Company financials

Revenue
$420M
Gross profit
$244M
Operating income
$17.3M
EBITDA
$108M
Net income
-$15.1M
EPS
-$0.10
Total assets
$1.5B
Total debt
$10.8M
Gross margin
58.12%
Net margin
-3.60%
Earnings yield
-0.80%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

4.166.128.0910.0612.02
CERT 1D NASDAQ O11.08H11.28L10.78C11.09+0.22 (+2.02%)Vol2.43M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
CERTCertara, Inc. Stock news Certara Q3 Earnings Call Highlights MarketBeat
CERTCertara, Inc. Stock news Certara, Inc. (CERT) Tops Q3 Earnings and Revenue Estimates Zacks Investment Research
CERTCertara, Inc. Stock news Certara Q3 revenue rises 4%, beats estimates Reuters
CERTCertara, Inc. Stock news BRIEF-Certara Q3 Adjusted EPS USD 0.09 Vs. IBES Estimate USD 0.09 Reuters
CERTCertara, Inc. Press release Certara Reports Third Quarter 2026 Financial Results GlobeNewswire
CERTCertara, Inc. Press release Birchtech Files Brief in Federal Circuit Supporting the $78 Million Patent Infringement Judgment Against CERT Defendants GlobeNewswire
CERTCertara, Inc. Press release Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026 GlobeNewswire
CERTCertara, Inc. Press release Higher Grades, More Ounces, Longer Life: The Playbook Taking Shape in Argentina’s Gold Belt GlobeNewswire
CERTCertara, Inc. Press release Cerrado Gold Reports 21% Year-Over-Year Increase in Q3 2026 Production Results at Minera Don Nicolas GlobeNewswire
CERTCertara, Inc. Stock news OneMedNet (NASDAQ:ONMD) and Certara (NASDAQ:CERT) Financial Comparison Defense World
CERTCertara, Inc. Press release The Market Just Told You Which Layer Of AI Biology It Is GlobeNewswire
CERTCertara, Inc. Stock news Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison Defense World
CERTCertara, Inc. Stock news BlackRock Inc. Acquires New Stake in Certara, Inc. $CERT Defense World
CERTCertara, Inc. Stock news Certara, Inc. (CERT) Q2 2026 Earnings Call Transcript Seeking Alpha
CERTCertara, Inc. Stock news Certara Q2 Earnings Call Highlights MarketBeat
CERTCertara, Inc. Stock news Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates Zacks Investment Research
CERTCertara, Inc. Press release Certara Reports Second Quarter 2026 Financial Results GlobeNewswire
CERTCertara, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT GlobeNewswire
CERTCertara, Inc. Press release Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 GlobeNewswire
CERTCertara, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT GlobeNewswire
See more
FAQ

Questions about Certara, Inc.

What does Certara, Inc. do?
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company uses biosimulation software, technology, and services to transform drug discovery and development, helping to bring medicines to patients. It also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. These technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access.
What is CERT's market cap?
Certara, Inc. (CERT) is a listed stock with a live quote. The latest market cap on this page is $1.8B.
Where is Certara, Inc. headquartered?
Certara, Inc. is headquartered in Princeton, NJ.
How do I get CERT news from the API?
Call GET /v1/news?tickers=CERT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does CERT news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for CERT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the CERT price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs